Exploiting microspheres as a therapeutic proficient doer for colon delivery: a review

Bibliography

• Mennini N, Furlanetto S, Cirri M, Quality by design approach for developing chitosan-Ca-alginate microspheres for colon delivery of celecoxib-hydroxypropyl-β-cyclodextrin-PVP complex. Eur J Pharm Biopharm 2012;80(1):67-75
   PubMed Web of Science ®Google Scholar
• Vemula SK, Veerareddy PR. Different approaches to design and evaluation of colon specific drug delivery systems. Int J Pharm Tech 2009;1(1):1-35
   Google Scholar
• Atyabi F, Majzooba S, Iman M, In vitro evaluation and modification of pectinate gel beads containing trimethyl chitosan, as a multi-particulate system for delivery of water soluble macromolecules to colon. Carbohydr Polym 2005;61:39-51
   Web of Science ®Google Scholar
• Aurora J, Talwar N, Pathak V. Colonic drug delivery challenges and opportunities – an overview. Eur Gastroenterol Rev 2006;1:1-6
   Google Scholar
• Rathbone MJ, Hadgraft J, Roberts MS. Modified release drug delivery technology. Marcel Dekker, Inc; New York: 2003
   Google Scholar
• Rodriguez M, Vila-Jato JL, Torres D. Design of a new multiparticulate system for potential site-specific and controlled drug delivery to the colonic region. J Control Release 1998;55:67-77
   PubMed Web of Science ®Google Scholar
• Sriamornsak P. Investigation of pectin as a carrier for oral delivery of proteins using calcium pectinate gel beads. Int J Pharm 1998;169:213-20
   Web of Science ®Google Scholar
• Elias P, Smart JD, Tsibouklis J. Azocrosslinked poly(acrylic acid) for colonic delivery and adhesion specificity: in vitro degradation and preliminary ex vivo bioadhesion studies. J Control Release 1998;54(1):95-9
   PubMed Web of Science ®Google Scholar
• Manjanna KM, Kumar SB, Kumar PTM. Diclofenac sodium microbeads for oral sustained drug delivery. Int J Pharm Tech Res 2009;1(2):317-27
   Google Scholar
• Jain A, Gupta Y, Jain SK. Potential of calcium pectinate beads for target specific drug release to colon. J Drug Target 2007;15(4):285-94
   PubMed Web of Science ®Google Scholar
• Atyabi F, Inanloo K, Dinarvand R. Bovine serum albumin-loaded pectinate beads as colonic peptide delivery system: preparation and in vitro characterization. Drug Deliv 2005;12(6):367-75
   PubMed Web of Science ®Google Scholar
• Ahmed IS. Effect of simulated gastrointestinal conditions on drug release from pectin/ethylcellulose as film coating for drug delivery to the colon. Drug Dev Ind Pharm 2005;31(4-5):465-70
   PubMed Web of Science ®Google Scholar
• Farlow SJ, Jerusalmi A, Sano T. Enhanced transduction of colonic cell lines in vitro and the inflamed colon in mice by viral vectors, derived from adeno-associated virus serotype 2, using virus-microbead conjugates bearing lectin. BMC Biotech 2007;7:83
   PubMedGoogle Scholar
• Singh BN, Kwon HK. Characterization and relevance of physicochemical interactions among components of a novel multiparticulate formulation for colonic delivery. Int J Pharm 2007;341:143-51
   PubMed Web of Science ®Google Scholar
• Pandey AK, Choudhary N, Raj VK, Fabrication and evaluation of tinidazole microbeads for colon targeting. Asian Pac J Trop Dis 2012;2(1):S197-01
   Google Scholar
• Mishra B, Jayanth P, Sankar C. Development of chitosan - alginate microcapsules for colon specific delivery of metronidazole. Ind Drug 2003;40(12):695-700
   Google Scholar
• Arimoto M, Fukumori Y, Fujiki J, Acrylic terpolymer microcapsules for colon-specific drug delivery: effect of molecular weight and solubility of microencapsulated drugs on their release behaviors. J Drug Deliv Sci Tech 2006;16(3):173-81
   Web of Science ®Google Scholar
• Singh A, Raghvendra, Kumar A, Development and characterization of microcapsule of flurbiprofen for colon specific drug delivery system. Eur J Bio Sci 2011;3(2):40-5
   Google Scholar
• Swetha A, Rao GM, Ramana VK, Formulation and in-vitro evaluation of etodolac entrapped in microsponge based drug delivery system. Int J Pharm 2011;1(2):73-80
   Google Scholar
• Comoglu T, Savaser A, Ozkan Y, Enhancement of ketoprofen bioavailability by formation of microsponge tablets. Pharmazie 2007;62:51-4
   PubMed Web of Science ®Google Scholar
• Srivastava R, Kumar D, Pathak K. Colonic luminal surface retention of meloxicam microsponges delivered by erosion based colon targeted matrix tablet. Int J Pharm 2012;427(2):153-62
   PubMedGoogle Scholar
• Jain V, Singh R. Dicyclomine-loaded eudragit-based microsponge with potential for colonic delivery: preparation and characterization. Trop J Pharm Res 2010;9(1):67-72
   Web of Science ®Google Scholar
• Anderson DL, Chung-Heng C, Nacht S. Flow characteristics of loosely compacted macroporous microsponge polymeric systems. Powder Technol 1994;78(1):15-18
   Web of Science ®Google Scholar
• Comoglu T, Gonul N, Baykara T. Preparation and in vitro evaluation of modified release ketoprofen microsponges. Farmaco 2003;58:101-6
   PubMedGoogle Scholar
• Orlu M, Erdal Cevher E, Araman A. Design and evaluation of colon specific drug delivery system containing flurbiprofen microsponges. Int J Pharm 2006;318:103-17
   PubMed Web of Science ®Google Scholar
• Kawashima Y, Niwa T, Takeuchi H, Hollow microspheres for use as a floating controlled drug delivery system in the stomach. J Pharm Sci 1992;82(2):135-40
   Google Scholar
• Mishra MK, Shikhri M, Sharma R, Optimization, formulation development and characterization of eudragit RS 100 loaded microsponges and subsequent colonic delivery. Int J Drug Discov Herbal Res 2011;1(1):8-13
   Google Scholar
• Alagsundaram M, Chetty MC, Attuluri UK, Microspheres-drug delivery system review. Int J Chem Tech Res 2009;1(3):526-34
   Google Scholar
• Jain SK, Ray G, Saraf DK, The preparation and evaluation of albendazole microspheres for colon delivery. Pharm Technol 2004;66-71
   Google Scholar
• Robinson JR, Lee VHL, Hui H. Design and fabrication of oral controlled release drug delivery system. In: Robinson JR, Lee VHL, editors. Controlled drug delivery: fundamental and applications. 2nd edition. Marcel Dekkar, New York; 1987. p. 373-4
   Google Scholar
• Masareddy RS, George JA. An overview on polymers used in development of drug delivery systems. Ind J Pharm Edu Res 2006;40(1):45-50
   Google Scholar
• Bajpai SK, Sonkusley J. Dynamic release of riboflavin from a colon-targeted drug delivery device: an in vitro study. React Funct Polym 2003;55(2):197-210
   Web of Science ®Google Scholar
• Giovannucci E, Rimm EB, Stampfer MJ, Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med 1994;121:241-6
   PubMed Web of Science ®Google Scholar
• Kune GA, Kune S, Watson LF. Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne colorectal cancer study. Cancer Res 1988;48:4399-404
   PubMed Web of Science ®Google Scholar
• Kune S, Kune GA, Watson LF. The melbourne colorectal cancer study: incidence findings by age, sex, site, migrants and religion. Int J Epidemiol 1986;15(4):483-93
   Web of Science ®Google Scholar
• Thun MJ, Namboodiri MM. Aspirin use and reduced risk of fatal colon cancer. Eng J Med 1991;325:1593-6
   PubMed Web of Science ®Google Scholar
• Craven PA, Thornburg K, Derubertis FR. Sustained increase in the proliferation of rat colonic mucosa during chronic treatment with aspirin. Gastroenterology 1988;94:567-75
   PubMed Web of Science ®Google Scholar
• Chan TA. Non steroidal anti inflammatory drugs, apoptosis and colon cancer chemoprevention. Lancet Oncol 2002;3:166-74
   PubMed Web of Science ®Google Scholar
• Thakral NK, Ray AR, Majumdar DK. Eudragit S100 entrapped chitosan microspheres of valdecoxib for colon cancer. J Mater Sci Mater Med 2010;21:2691-9
   PubMed Web of Science ®Google Scholar
• Thakral NK, Ray AR, Bar- shalom D, The quest for targeted delivery in colon cancer: mucoadhesive valdecoxib microspheres. Int J Nanomed 2011;6:1057-68
   PubMed Web of Science ®Google Scholar
• Vats A, Pathak K. Tabletted guar gum microspheres of piroxicam for targetted adjuvant therapy for colonic adenocarcinoma. Ther Deliv 2012;3(11):1281-95
   PubMedGoogle Scholar
• Rahman Z, Kohli K, Khar RK, Characterization of 5- fluorouracil microspheres for colonic delivery. AAPS Pharm Sci Tech 2006;7(2):E113-21
   Web of Science ®Google Scholar
• Mandal TK. Development of biodegradable drug delivery system to treat addiction. Drug Dev Ind Pharm 1999;25:773-9
   PubMed Web of Science ®Google Scholar
• Lamprecht A, Yammoto H, Taeuchi H, Microspheres design for colonic delivery of 5- fluorouracil. J Control Release 2003;90:313-22
   PubMed Web of Science ®Google Scholar
• Shivani N, Hetal P, Rajesh K, Colon delivery of 5- fluorouracil using cross-linked chitosan microspheres coated with eudragit S 100. Int J Drug Deliv 2011;3(2):260-8
   Google Scholar
• Ganguly K, Aminabhavi TM, Kulkarni AR. Colon targeting of 5-fluorouracil using polyethylene glycol cross-linked chitosan microspheres enteric coated with cellulose acetate phthalate. Ind Eng Chem Res 2011;50(21):11797-807
   Web of Science ®Google Scholar
• Chaturvedi K, Kulkarni AR, Aminabhavi TM. Blend microspheres of poly (3-hydroxybutyrate) and cellulose acetate phthalate for colon delivery of 5-fluorouracil. Ind Eng Chem Res 2011;50(18):10414-23
   Web of Science ®Google Scholar
• Paharia A, Yadav AK, Rai G, Eudragit-coated pectin microspheres of 5-fluorouracil for colon targeting. AAPS PharmSciTech 2007;8(1):E1-7
   PubMedGoogle Scholar
• Dhawale SC, Bankar AS, Patro MN. Formulation and evaluation porous microspheres of 5- fluorouracil for colon targeting. Int J Pharm Tech Res 2010;2(2):1112-18
   Google Scholar
• Chaurasia M, Chaurasia MK, Jain NK, Cross-linked guar gum microspheres: a viable approach for improved delivery of anticancer drugs for the treatment of colorectal Cancer. AAPS Pharm Sci Tech 2006;7(3):E143-51
   Web of Science ®Google Scholar
• Dai M, Xu X, Song J, Preparation of camptothecin-loaded PCEC microspheres for the treatment of colorectal peritoneal carcinomatosis and tumor growth in mice. Cancer Lett 2011;312(2):189-96
   PubMed Web of Science ®Google Scholar
• Zhang L, Cao F, Ding B, Eudragit S100 coated calcium pectinate microspheres of curcumin for colon targeting. J Microencapsul 2011;28(7):659-67
   PubMed Web of Science ®Google Scholar
• Lu B, Zhang Z. Novel colon-specific microspheres with highly dispersed hydroxyl camptothecin cores: their preparation, release behavior, and therapeutic efficiency against colonic cancer. J Pharm Sci 2006;95(12):2619-30
   PubMed Web of Science ®Google Scholar
• Gao Y, Zhu C-L, Zhang X-X, Lipidpolymer composite microspheres for colon-specific drug delivery prepared using an ultrasonic spray freeze-drying technique. J Microencapsul 2011;28(6):549-56
   PubMed Web of Science ®Google Scholar
• Hardy FH, David SS, Khosala R, Gastrointestinal transit of small tablets in patients with ulcerative colitis. Int J Pharmcol 1998;48:79-82
   Google Scholar
• Lamprecht A, Yamamoto H, Takeuchi H, A pH-sensitive microsphere system for colon delivery of tacrolimus containing nanoparticles. J Control Release 2005;104(2):337-46
   PubMed Web of Science ®Google Scholar
• Lamprecht A, Yamamoto H, Ubrich N, FK506 microparticles mitigate experimental colitis with minor renal calcineurin suppression. Pharm Res 2005;22(2):193-9
   PubMed Web of Science ®Google Scholar
• Dandagi PM, Mastiholimath VS, Gadad AP, pH-sensitive mebeverine microspheres for colon delivery. Ind J Pharm Sci 2009;71(4):464-8
   PubMed Web of Science ®Google Scholar
• Keitzmann D, Moulari B, Beduneau A, Colonic delivery of carboxyfluorescein by pH-sensitive microspheres in experimental colitis. Eur J Pharm Biopharm 2010;76(2):290-5
   PubMed Web of Science ®Google Scholar
• Dubey R, Dubey R, Omrey P, Development and characterization of colon specific drug delivery system bearing 5-ASA and camylofine dihydrochloride for the treatment of ulcerative colitis. J Drug Target 2010;18(8):589-601
   PubMed Web of Science ®Google Scholar
• Nakase H, Okazak K, Tabata Y, Biodegradable microspheres targeting mucosal immune-regulating cells: new approach for treatment of inflammatory bowel disease. J Gastroenterol 2003;38(15):59-62
   PubMed Web of Science ®Google Scholar
• Dashora A, Jain CP. Development and characterization of pectin-prednisolone microspheres for colon targeted delivery. Int J Chem Tech Res 2009;1(3):751-7
   Google Scholar
• Masterelli F, Zerrou KN, Cirria M, Microspheres for colonic delivery of Ketoprofen-hydroxypropyl- β-cyclone dextrin complex. Eur J Pharm Biopharm 2008;34(1):1-11
   Web of Science ®Google Scholar
• Kushwaha P, Fareed S, Nanda S, Design and fabrication of tramadol HCl loaded multiparticulate colon targeted drug delivery system. J Chem Pharm Res 2011;3(5):584-95
   Google Scholar
• Patel MM, Amin AF. Process, optimization and characterization of mebeverine hydrochloride loaded guar gum microspheres for irritable bowel syndrome. Carbohydr Polym 2011;86(2):536-54
   Web of Science ®Google Scholar
• Mahajan NM, Sakarkar DMDR, Manmode AS. Therapeutic potential of biodegradable meselamine microspheres in the treatment of ulcerative colitis. Asian J Pharm Clin Res 2011;4(1):120-5
   Google Scholar
• El- Bary AA, Aboelwafa AA, Sharabi IM. Influence of some formulation variables on the optimization of pH-dependent, colon-targeted, sustained-release mesalamine microspheres. AAPS Pharm Sci Tech 2011;13(1):75-84
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Dehkordi JA, Golafshan S. Colon-specific delivery of mesalazine chitosan microspheres. J Microencapsul 2006;23(3):329-39
   PubMed Web of Science ®Google Scholar
• Chandran S, Sanjay KS, Ali Asghar LF. Microspheres with pH modulated release: design and characterization of formulation variables for colonic delivery. J Microencapsul 2009;26(5):420-31
   PubMed Web of Science ®Google Scholar
• Vijay S, Sati OP, Majumdar DK. Acrylic acid-methyl methacrylate (2.5:7.5/2:8) enteric copolymer for colon targeted drug delivery. J Mater Sci Mater Med 2011;22(1):125-35
   PubMed Web of Science ®Google Scholar
• Kumar SR, Piyush T, Suman R, Preparation and characterization of cross-linked guar gum microspheres: optimization using factorial design. Chem Pharm Bull 2011;59(2):185-90
   PubMed Web of Science ®Google Scholar
• Shukla S, Jain D, Verma K, Formulation and in vitro characterization of alginate microspheres loaded with diloxanide furoate for colon- specific drug delivery. Asian J Pharm 2010;4(4):199-204
   Google Scholar
• Chourasia MK, Jain SK. Design and development of multiparticulate system for targeted drug delivery to colon. Drug Deliv 2004;11(3):201-7
   PubMed Web of Science ®Google Scholar
• Gray B, Van Hazel G, Hope M, Randomised trial of sir-spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol 2001;12:1711-20
   PubMed Web of Science ®Google Scholar
• Van Hazel GA, Pavlakis N, Goldstein D, Treatment of fluorouracil-refractory patients with liver metastases from colorectal cancer by using yttrium-90 resin microspheres plus concomitant systemic irinotecan chemotherapy. J Clin Oncol 2009;27(25):4089-95
   PubMed Web of Science ®Google Scholar
• Cosimelli M, Golfieri M, Cagol PP, Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases. Br J Cancer 2010;103(3):324-31
   PubMed Web of Science ®Google Scholar
• Gulec SA, Pennington K, Wheeler J, Yttrium-90 microsphere-selective internal radiation therapy with chemotherapy (Chemo-SIRT) for colorectal cancer liver metastases: an in vivo double-arm-controlled phase II trial. Am J Clin Oncol 2012; published online
   Google Scholar
• Jose S, Prema MT, Chacko AJ, Colon specific chitosan microspheres for chronotherapy of chronic stable angina. Eur J Pharm Biopharm 2011;89:277-83
   Google Scholar
• Vaidya A, Jain A, Khare P, Metronidazole loaded pectin microspheres for colon targeting. J Pharm Sci 2009;98(11):4229-36
   PubMed Web of Science ®Google Scholar